Faron Pharmaceuticals - Innovatiivisia lääketieteen ratkaisuja (Osa 2)

[Tuul1puku]

@Roni

Lind and Syrjälä have been on the sell side, so the probability of a share issue is likely elevated.

And especially a directed issue. A public offering takes much more time and it might align poorly with Dekkers’ sales from an insider information perspective.